Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Potassium Citrate (1100mg/5ml) + Magnesium Citrate (375mg/5ml) + Vitamin B6 (Pyridoxine) (20mg/5ml)
Therapeutic Category
Nephrology, Urology, Nutraceuticals, Multivitamins and Multiminerals
Dosage Form
Syrup
Packaging Type
with Carton
Packaging
200 ml
Price
₹210/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga B6 Syrup is a specialized formulation aimed at promoting urinary health and preventing the recurrence of kidney stones. This syrup combines the therapeutic benefits of Potassium Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine) to support kidney function and maintain a healthy urinary environment.
Potassium Citrate works by alkalizing the urine, reducing acidity levels, and minimizing the formation of uric acid and calcium oxalate stones. It enhances citrate levels in urine, which is a natural inhibitor of stone formation. Magnesium Citrate complements this by binding to oxalate, reducing its availability for kidney stone formation. Additionally, Vitamin B6 (Pyridoxine) decreases oxalate production in the body, further preventing stone formation while supporting overall metabolic health.
Uriviga B6 Syrup is especially effective for individuals prone to recurrent kidney stones and those diagnosed with conditions such as hypocitraturia (low urinary citrate levels). Its balanced composition helps improve urinary alkalinity and reduces the likelihood of future stone formation. The syrup form ensures ease of administration and better patient compliance, particularly for those who may have difficulty swallowing tablets.
Potential side effects include mild gastrointestinal discomfort, nausea, or diarrhea. Rarely, allergic reactions may occur.
Uriviga B6 Syrup is indicated for the prevention of kidney stone formation, management of low urinary citrate levels, and maintenance of healthy urinary pH.
Use under medical supervision. Avoid exceeding the recommended dose. If symptoms persist or worsen, consult a healthcare professional promptly.
Store in a cool, dry place at temperatures below 30°C, away from direct sunlight. Keep out of reach of children.
Composition : Potassium Citrate (978mg) + Magnesium Citrate (263.10mg) + Vitamin B6 (Pyridoxine) (15mg)
Composition : Flavoxate (200mg)
Composition : Diclofenac (50mg) + Metaxalone (400mg)
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
Composition : Etodolac (400mg) + Thiocolchicoside (4mg)
Composition : Drotaverine (80mg) + Mefenamic Acid (250mg)
Composition : Chlorzoxazone (250mg) + Diclofenac (50mg) + Paracetamol (325mg)
Composition : Baclofen (10mg) Tablet
Composition : Baclofen (20mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This is a urology and kidney care supportive syrup used for the management of kidney stones (renal calculi), urinary tract discomfort, burning urination, and prevention of stone recurrence. Potassium Citrate helps alkalinize urine and prevents stone formation Magnesium Citrate reduces stone crystallization Vitamin B6 helps reduce oxalate formation It is a strong urology, nephrology support, and urinary care segment product.
Medical distributors and wholesalers can benefit from consistent prescription demand from urologists, nephrologists, and general physicians. Kidney stones and urinary issues are highly common in India due to diet and lifestyle factors, ensuring steady chronic and repeat prescriptions and strong retail demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in urology, nephrology, and renal care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prevalence of kidney stone cases, long-term preventive therapy usage, and repeat prescription cycles, making it a stable, prescription-driven, and growing pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in urology and renal care formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the kidney and urinary care segment.